Provocative tests with psychostimulant drugs in schizophrenia.
about
Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?Reduced crowding and poor contour detection in schizophrenia are consistent with weak surround inhibitionMethyiphenidate vs. amphetamine: Comparative reviewThe dopamine hypothesis of schizophrenia: version III--the final common pathwaySingle photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjectsAnimal models of schizophrenia: a critical reviewTreating Negative Symptoms in Schizophrenia: an UpdateThe Role of Dopamine and Its Dysfunction as a Consequence of Oxidative StressMaking Sense of: Sensitization in SchizophreniaPsychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gapHistory of the discovery of the antipsychotic dopamine D2 receptor: a basis for the dopamine hypothesis of schizophreniaβ-phenylethylamine, a small molecule with a large impactFrom pan-reactive KV7 channel opener to subtype selective opener/inhibitor by addition of a methyl groupAmphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunctionAll Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High ReceptorsThe Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for PsychosisDopaminergic contributions to hippocampal pathophysiology in schizophrenia: a computational studySubcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging.Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses.Dexamphetamine selectively increases 40 Hz auditory steady state response power to target and nontarget stimuli in healthy humans.Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia.Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia?Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits.Locomotor hyperactivity in 14-3-3ζ KO mice is associated with dopamine transporter dysfunction.MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variantDopamine as the wind of the psychotic fire: new evidence from brain imaging studies.An Integrative Perspective on the Role of Dopamine in SchizophreniaDisruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex.An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia.Maternal immune activation alters nonspatial information processing in the hippocampus of the adult offspring.Treatment of the psychostimulant-sensitized animal model of schizophrenia.Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia.Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders.Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases.Is schizophrenia a dopamine supersensitivity psychotic reaction?Presynaptic regulation of dopamine transmission in schizophrenia.Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light.Pathway-Specific Dopamine Abnormalities in Schizophrenia.
P2860
Q21260315-8B4D0B03-353F-48D6-BE46-40DD7E2BD9A7Q21559665-445868D4-361B-44D5-8C8A-12C731BC2498Q22241805-F2CC58B8-792A-47AC-BDB7-91CE02961BB5Q22242827-B3EA63B9-83B5-485F-8436-D36561B76E58Q22248075-898594BD-6E9A-49EA-B41A-D9AA8B1E04E3Q24674909-4DA75249-B338-4ECC-9CE2-D5F9F68EF114Q26744805-1B0494C2-300D-404A-A200-8BABAA5FA127Q26771824-0727AB56-A77F-47B6-B7DD-B8F21625526EQ28077939-96EAEF61-0881-41BF-93D8-F9DE6BFEE40BQ28081111-D9572BAB-C3D6-4116-8344-AF893938EF77Q28283494-2D5A55F5-68BF-4E83-8EE2-58F32DA8EE39Q28306989-E0A311CC-2C30-42D5-8E76-4AA92A0FDEC7Q28539924-6FE07C7E-BEA2-4D28-A5A3-C9D021457F77Q28590145-B9328C3F-BC8C-4EA2-9EDF-1AEBABC15ED3Q29395121-50049A60-ABF4-473C-8ACA-B8DD6F52C933Q30047193-1262EEF6-0C84-4908-89DB-0336C709D547Q30410514-8FFBB262-5724-4411-B310-510750307309Q30440091-5C8D8987-3649-44BC-B19B-7AEE74C24C8AQ30454141-C2EC392D-6A85-4E24-8445-60E0C03612F3Q30459202-2CEF95DF-3D17-417E-AECE-817B8AA907C2Q30475712-96E5693C-0194-48E2-B24F-BE62E8737749Q30491317-DE427B26-81A2-41E3-895E-9B45BC49BC47Q30685335-766BD161-09B3-4DA0-B160-BDF5F13C7A94Q30826347-F64794F9-E1AB-41CE-9C4B-30F04764AA8EQ33647525-BDA52C92-F1A9-4247-8AB0-75776D3737B8Q33676705-7B891A1A-A09E-48BE-8CC4-7174C2B754D0Q33833648-D0A86FA9-611C-47C8-96FB-2E6575FAF9DBQ33839379-53492141-A520-4CF4-9049-6BA7625C9DD0Q33893744-92AB385D-9E63-43D2-ADFA-460171F2728FQ33933997-79252DF6-9AAA-498E-BA13-C871F8FAF19FQ33965514-6EC87C93-108B-4A9E-8AC7-3312B8692018Q34155012-BEE7B7D1-B193-4FFC-BF9C-52D0E4A7301AQ34169978-7253FAE4-EC0E-4476-AC7D-CC297B3C50DFQ34272454-F9EFB74B-B682-44E1-A21F-42F9635BE257Q34330678-A1FAA7EB-B465-42ED-AC68-CED2886CF545Q34350145-79EB41FC-C34C-4945-9283-F8BCCC1D47C6Q34377871-56CDE380-D0E5-4C40-8DDD-EB4C69564382Q34415890-0F047A26-EB41-484A-9E0F-58B870A68A13Q34509725-E5B34F6D-47ED-482A-B47E-6518A6EDCDD1Q34527656-4BBABCA8-8007-43D3-AF91-5D1CBC232095
P2860
Provocative tests with psychostimulant drugs in schizophrenia.
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Provocative tests with psychostimulant drugs in schizophrenia.
@ast
Provocative tests with psychostimulant drugs in schizophrenia.
@en
Provocative tests with psychostimulant drugs in schizophrenia.
@nl
type
label
Provocative tests with psychostimulant drugs in schizophrenia.
@ast
Provocative tests with psychostimulant drugs in schizophrenia.
@en
Provocative tests with psychostimulant drugs in schizophrenia.
@nl
prefLabel
Provocative tests with psychostimulant drugs in schizophrenia.
@ast
Provocative tests with psychostimulant drugs in schizophrenia.
@en
Provocative tests with psychostimulant drugs in schizophrenia.
@nl
P2093
P2860
P356
P1433
P1476
Provocative tests with psychostimulant drugs in schizophrenia.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF00216006
P577
1987-01-01T00:00:00Z
P6179
1047611583